Search research articles
Contact Us
Filters
Showing results (11-20 of 28) with videos related to
Page
of 3
Sort By:
Journal of Forensic Sciences
|
October 15, 2013
Combustion and toxic gas production from disposable barbecues in enclosures
Robert J Crewe, Stephen P Andrews, T Richard Hull, et al.
Nature Neuroscience
|
September 18, 2024
Inhibiting Ca<sup>2+</sup> channels in Alzheimer's disease model mice relaxes pericytes, improves cerebral blood flow and reduces immune cell stalling and hypoxia
Nils Korte, Anna Barkaway, Jack Wells, et al.
Journal of Medicinal Chemistry
|
June 14, 2011
Biophysical mapping of the adenosine A2A receptor
Andrei Zhukov, Stephen P Andrews, James C Errey, et al.
ACS Medicinal Chemistry Letters
|
November 19, 2025
Development of Purine and Pyrrolopyrimidine Scaffolds as Potent, Selective, and Brain Penetrant NUAK1 Inhibitors
Gregory G Aldred, Helen K Boffey, Henriette M G Willems, et al.
ACS Medicinal Chemistry Letters
|
August 25, 2020
Systematic Investigation of the Permeability of Androgen Receptor PROTACs
Duncan E Scott, Timothy P C Rooney, Elliott D Bayle, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
May 18, 2007
Total synthesis of five thapsigargins: guaianolide natural products exhibiting sub-nanomolar SERCA inhibition
Stephen P Andrews, Matthew Ball, Frank Wierschem, et al.
RSC Medicinal Chemistry
|
October 20, 2023
The rational design of ARUK2007145, a dual inhibitor of the α and γ isoforms of the lipid kinase phosphatidylinositol 5-phosphate 4-kinase (PI5P4K)
Gregory G Aldred, Timothy P C Rooney, Henriette M G Willems, et al.
RSC Medicinal Chemistry
|
May 30, 2023
Identification of ARUK2002821 as an isoform-selective PI5P4Kα inhibitor
Henriëtte M G Willems, Simon Edwards, Helen K Boffey, et al.
Journal of Medicinal Chemistry
|
January 19, 2012
Identification of novel adenosine A(2A) receptor antagonists by virtual screening
Christopher J Langmead, Stephen P Andrews, Miles Congreve, et al.
ACS Medicinal Chemistry Letters
|
February 19, 2025
Development of the Pyrido[2,3-<i>d</i>]pyrimidin-7(8<i>H</i>)-one Scaffold toward Potent and Selective NUAK1 Inhibitors
Timothy P C Rooney, Gregory G Aldred, David Winpenny, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 28) with videos related to
Sort By:
Page
of 3
Journal of Forensic Sciences
|
October 15, 2013
Combustion and toxic gas production from disposable barbecues in enclosures
Robert J Crewe, Stephen P Andrews, T Richard Hull, et al.
Nature Neuroscience
|
September 18, 2024
Inhibiting Ca<sup>2+</sup> channels in Alzheimer's disease model mice relaxes pericytes, improves cerebral blood flow and reduces immune cell stalling and hypoxia
Nils Korte, Anna Barkaway, Jack Wells, et al.
Journal of Medicinal Chemistry
|
June 14, 2011
Biophysical mapping of the adenosine A2A receptor
Andrei Zhukov, Stephen P Andrews, James C Errey, et al.
ACS Medicinal Chemistry Letters
|
November 19, 2025
Development of Purine and Pyrrolopyrimidine Scaffolds as Potent, Selective, and Brain Penetrant NUAK1 Inhibitors
Gregory G Aldred, Helen K Boffey, Henriette M G Willems, et al.
ACS Medicinal Chemistry Letters
|
August 25, 2020
Systematic Investigation of the Permeability of Androgen Receptor PROTACs
Duncan E Scott, Timothy P C Rooney, Elliott D Bayle, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
May 18, 2007
Total synthesis of five thapsigargins: guaianolide natural products exhibiting sub-nanomolar SERCA inhibition
Stephen P Andrews, Matthew Ball, Frank Wierschem, et al.
RSC Medicinal Chemistry
|
October 20, 2023
The rational design of ARUK2007145, a dual inhibitor of the α and γ isoforms of the lipid kinase phosphatidylinositol 5-phosphate 4-kinase (PI5P4K)
Gregory G Aldred, Timothy P C Rooney, Henriette M G Willems, et al.
RSC Medicinal Chemistry
|
May 30, 2023
Identification of ARUK2002821 as an isoform-selective PI5P4Kα inhibitor
Henriëtte M G Willems, Simon Edwards, Helen K Boffey, et al.
Journal of Medicinal Chemistry
|
January 19, 2012
Identification of novel adenosine A(2A) receptor antagonists by virtual screening
Christopher J Langmead, Stephen P Andrews, Miles Congreve, et al.
ACS Medicinal Chemistry Letters
|
February 19, 2025
Development of the Pyrido[2,3-<i>d</i>]pyrimidin-7(8<i>H</i>)-one Scaffold toward Potent and Selective NUAK1 Inhibitors
Timothy P C Rooney, Gregory G Aldred, David Winpenny, et al.
Page
of 3